Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction
Tóm tắt
Obesity is associated with insulin resistance that can often be improved by caloric restriction and weight reduction. Although many physiological changes accompanying insulin resistance and its treatment have been characterized, the genetic mechanisms linking obesity to insulin resistance are largely unknown. We used DNA microarrys and RT-PCR to investigate significant changes in hepatic gene transcription in insulin resistant, diet-induced obese (DIO)-C57/BL/6J mice and DIO-C57/BL/6J mice fasted for 48 hours, whose weights returned to baseline levels during these conditions. Transcriptional profiling of hepatic mRNA revealed over 1900 genes that were significantly perturbed between control, DIO, and fasting/weight reduced DIO mice. From this set, our bioinformatics analysis identified 41 genes that rigorously discriminate these groups of mice. These genes are associated with molecular pathways involved in signal transduction, and protein metabolism and secretion. Of particular interest are genes that participate in pathways responsible for modulating insulin sensitivity. DIO altered expression of genes in directions that would be anticipated to antagonize insulin sensitivity, while fasting/ weight reduction partially or completely normalized their levels. Among these discriminatory genes, Sh3kbp1 and RGS3, may have special significance. Sh3kbp1, an endogenous inhibitor of PI-3-kinase, was upregulated by high-fat feeding, but normalized to control levels by fasting/weight reduction. Because insulin signaling occurs partially through PI-3-kinase, increased expression of Sh3kbp1 by DIO mice may contribute to hepatic insulin resistance via inhibition of PI-3-kinase. RGS3, a suppressor of G-protein coupled receptor generation of cAMP, was repressed by high-fat feeding, but partially normalized by fasting/weight reduction. Decreased expression of RGS3 may augment levels of cAMP and thereby contribute to increased, cAMP-induced, hepatic glucose output via phosphoenolpyruvate carboxykinase (PCK1), whose mRNA levels were also elevated. These findings demonstrate that hepatocytes respond to DIO and weight reduction by controlling gene transcription in a variety of important molecular pathways. Future studies that characterize the physiological significance of the identified genes in modulating energy homeostasis could provide a better understanding of the mechanisms linking DIO with insulin resistance.
Tài liệu tham khảo
Keller K, Lemberg L: Obesity and the Metabolic Syndrome. American Journal of Critical Care. 2003, 12 (2): 167-170.
Goran MI, Ball GD, Cruz ML: Obesity and Risk of Type 2 Diabetes and Cardiovascular Disease in Children and Adolescents. Journal of Clinical Endocrinology and Metabolism. 2003, 88 (4): 1417-1427. 10.1210/jc.2002-021442.
youn Kim S, il Kim H, Park SK, Im SS, Li T, Cheon HG, ho Ahn Y: Liver Glucokinase can be Activated by Peroxisome Proliferator-Activated Receptor-gamma. Diabetes. 2004, 53 (Supplement 1): S66-S70.
Kerstein S, Desvergne B, Wahli W: Roles of PPARs in Health and Disease. Nature. 2000, 405: 421-424. 10.1038/35013000.
Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA: Control of Pancreas and Liver Gene Expression by HNF Transcription Factors. Nature. 2004, 303: 1378-1381. 10.1126/science.1089769.
Christ B, Yazici E, Nath A: Phosphatidylinositol 3-kinase and Protein Kinase C Contribute to the Inhibition by Interleukin 6 of Phosphoenolpyruvate Carboxykinase Gene Expression in Cultured Hepatocytes. Hepatology. 2000, 31: 461-468. 10.1002/hep.510310228.
Surwit R, Kuhn C, Cochrane C, McCubbin J, Feinglos M: Diet-induced Type II Diabetes in C57BL/6J Mice. Diabetes. 1988, 37 (9): 1163-1167.
Parekh P, Petro A, Tiller J, Feinglos M, Surwit R: Reversal of Diet-induced Obesity and Diabetes in C57BL/6J Mice. Metabolism. 1998, 47 (9): 1089-1096. 10.1016/S0026-0495(98)90283-9.
Frederich R, Hamann A, Anderson S, Lollmann B, Flier J: Leptin Levels Reflect Body Lipid Content in Mice: Evidence for Diet-Induced Resistance to Leptin Action. Nature Medicine. 1995, 1: 1311-1314. 10.1038/nm1295-1311.
El-Haschimi K, Pierroz D, Hileman S, Bjorbaek C, Flier J: Two Defects Contribute to Hypothalamic Leptin Resistance in Mice with Diet-Induced Obesity. Journal of Clinical Investigation. 2000, 105: 1827-1832.
Lin S, Thomas T, Storlien L, Huang X: Development of High Fat Diet-Induced Obesity and Leptin Resistance in C57Bl/6J Mice. International Journal of Obesity and Related Metabolic Disorders. 2000, 24: 639-646. 10.1038/sj.ijo.0801209.
Belfiore F, Ianneloo S, Rabuazzo A, Campione R: Metabolic Effects of Short-Term Fasting in Obese Hyperglycaemic Humans and Mice. International Journal of Obesity. 1987, 11: 631-640.
O'Brien RM, Granner DK: Regulation of Gene Expression by Insulin. Physiological Reviews. 1996, 76 (4): 1109-1161.
Jr AWF, Thearle M, Liao T, Leibel RL: Effects of Leptin Deficiency and Short-term Repletion on Hepatic Gene Expression in Genetically Obese Mice. Diabetes. 2001, 50 (10): 2268-2278.
Tobe K, Suzuki R, Aoyama M, Terauchi Y: Increased Expression of SREBP-1 Gene in IRS-2(-/-) Mice Liver. Diabetes. 2001, 50 (Supplement 2): A324-A324.
Ziotopoulou M, Mantzoros C, Hileman S, Flier J: Differential Expression of Hypothalamic Neuropeptides in the Early Phase of Diet-Induced Obesity in Mice. American Journal of Physiology: Endocrinology and Metabolism. 2000, 279 (4): E838-E845.
Bullen JW, Ziotopoulou M, Ungsunan L, Misra J, Alevizos I, Kokkotou E, Maratos-Flier E, Stephanopoulos G, Mantzoros CS: Short-term Resistance to Diet-Induced Obesity in A/ J Mice is Not Associated with Regulation of Hypothalamic Neuropeptides. American Journal of Physiology: Endocrinology and Metabolism. 2004,
Jelinsky S, Samson L: Global Response of Saccharomyces cerevisiae to an Alkylating Agent. Proceedings of the National Academy of Sciences – USA. 1999, 96: 1486-1491. 10.1073/pnas.96.4.1486.
Wang Y, Rea T, Bian J, Gray S, Sun Y: Identification of the Genes Responsive to Etoposide-induced Apoptosis: Application of DNA Chip Technology. FEBS Letters. 1999, 445: 269-273. 10.1016/S0014-5793(99)00136-2.
Ruan H, Hacohen N, Golub TR, Parijs LV, Lodish HF: Tumor Necrosis Factor-α Suppresses Adipocyte-Specific Genes and Activates Expression of Preadipocyte Genes in 3T3-L1 Adipocytes. Diabetes. 2002, 51: 1319-1336.
Nadon R, Shoemaker J: Statistical Issues with Microarrays: Processing and Analysis. TRENDS in Genetics. 2002, 18 (5): 265-271. 10.1016/S0168-9525(02)02665-3.
Quackenbush J: Computational Analysis of Microarray Data. Nature Reviews Genetics. 2001, 2 (6): 418-427. 10.1038/35076576.
Kuruvilla FG, Park PJ, Schreiber SL: Vector Algebra in the Analysis of Genome-wide Expression Data. Genome Biology. 2002, 3 (3): 0011.1-0011.11. 10.1186/gb-2002-3-3-research0011.
Thomas JG, Olson JM, Tapscott SJ, Zhao LP: An Efficient and Robust Statistical Modeling Approach to Discover Differentially Expressed Genes using Genomic Expression Profiles. Genome Research. 2001, 11: 1227-1236. 10.1101/gr.165101.
Hwang D, Schmitt WA, Stephanopoulos G, Stephanopoulos G: Determination of Minimum Sample Size and Discriminatory Expression Patterns. Bioinformatics. 2002, 18: 1184-1193. 10.1093/bioinformatics/18.9.1184.
Stephanopoulos G, Hwang D, Schmitt WA, Misra J, Stephanopoulos G: Mapping Physiological States from Microarray Expression Measurements. Bioinformatics. 2002, 18 (8): 1054-1063. 10.1093/bioinformatics/18.8.1054.
Dillon WR, Goldstein M: Multivariate Analysis: Methods and Applications. 1984, New York: John Wiley & Sons
Bioinformatics and Metabolic Engineering Laboratory at MIT. http://web.mit.edu/bamel/index.shtml
Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI Gene Expression and Hybridization Array Data Repository. Nucleic Acids Research. 2002, 30: 207-210. 10.1093/nar/30.1.207.
Escalante-Pulido M, Escalante-Herrera A, Milke-Najar M, Alpizar-Salazar M: Effects of Weight Loss on Insulin Secretion and in vivo Insulin Sensitivity in Obese Diabetic and Non-diabetic Subjects. Diabetes Nutrition and Metabolism. 2003, 16: 277-283.
Heilbronn LK, Ravussin E: Calorie Restriction and Aging: Review of the literature and implications for studies in humans. American Journal of Clinical Nutrition. 2003, 78: 361-369.
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of Leptin in the Neuroendocrine Response to Fasting. Nature. 1996, 383: 250-252. 10.1038/382250a0.
Koch W, Hawes B, Allen L, Lefkowitz R: Direct Evidence that G i -Coupled Receptor Stimulation of Mitogen-Activated Protein Kinase is Mediated by G βγ Activation of p21ras. Proceedings of the National Academy of Sciences: U S A. 1994, 91: 12706-12710.
Kullander K, Klein R: Mechanisms and Functions of EPH and EPHRIN Signalling. Nature Reviews Molecular Cell Biology. 2002, 3: 475-486. 10.1038/nrm856.
Verdier F, Valovka T, Zhyvoloup A, Drobot LB, Buchman V, Waterfiedl M, Gout I: Ruk is Ubiquitinated but not Degraded by the Proteasome. European Journal of Biochemistry. 2002, 269: 3402-3408. 10.1046/j.1432-1033.2002.03031.x.
White MF, Jr MGM: Diabetes Mellitus, Carbohydrate Metabolism, and Lipid Disorders. 2000, Canada: Harcourt Canada
Gout I, Middleton G, Adu J, Ninkina NN, Drobot LB, Filonenko V, Matsuka G, Davies AM, Waterfield M, Buchman VL: Negative Regulation of PI 3-kinase by Ruk, a Novel Adaptor Protein. EMBO Journal. 2000, 19 (15): 4015-4025. 10.1093/emboj/19.15.4015.
Cheng A, Dube N, Gu F, Tremblay ML: Coordinated Action of Protein Tyrosine Phosphatases in Insulin Signal Transduction. European Journal of Biochemistry. 2002, 269: 1050-1059. 10.1046/j.0014-2956.2002.02756.x.
Asante-Appiah E, Kennedy BP: Protein Tyrosine Phosphatases: The quest for negative regulators of insulin action. American Journal of Physiology, Endocrinology and Metabolism. 2003, 284: E663-E670.
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy A, Normandin D, Cheng A, Himms-Hang J, Chan C, Ramachandran C, Gresser M, Tremblay M, Kennedy B: Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B Gene. Science. 1999, 283: 1544-1548. 10.1126/science.283.5407.1544.
Arshavsky V, Jr EP: Lifetime Regulation of G Protein-Effector Complex: Immerging Importance of RGS Proteins. Neuron. 1998, 20: 11-14. 10.1016/S0896-6273(00)80430-4.
Jeong S, Ikeda S: Endogenous Regulator of G-Protein Signalling Proteins Modify N-type Calcium Channel Modulation in Rat Sympathetic Neurons. Journal of Neuroscience. 2000, 20: 4489-4496.
Sinnarajah S, Dessauer CW, Srikumar D, Chen J, Yuen J, Yilma S, Dennis JC, Morrison EE, Vodyanoy V, Kehrl JH: RGS2 Regulates Signal Transduction in Olfactory Neurons by Attenuating Activation of Adenylyl Cyclase III. Nature. 2001, 409: 1051-1055. 10.1038/35059104.
Chan R, Otte C: Isolation and Genetic Analysis of Saccharomyces cerevisiae Mutants Supersensitive to G1 Arrest by a Factor and α-factor Pheromones. Molecular Cellular Biology. 1982, 2: 11-20.
Vries LD, Zheng B, Fischer T, Elenko E, Farquhar M: The Regulator of G Protein Signalling Family. Annual Reviews in Pharmacology and Toxicology. 2000, 40: 235-271. 10.1146/annurev.pharmtox.40.1.235.
Siderovski D, Strockbine B, Behe C: Whither goest the RGS proteins?. Critical Reviews in Biochemistry and Molecular Biology. 1999, 34: 215-251. 10.1080/10409239991209273.
Chatterjee TK, Eapen AK, Fisher RA: A Truncated Form of RGS3 Negatively Regulates G Protein-coupled Receptor Stimulation of Adenylyl Cyclase and Phosphoinositide Phospholipase C. The Journal of Biological Chemistry. 1997, 272 (24): 15481-15487. 10.1074/jbc.272.24.15481.
Neubig RR, Siderovski DP: Regulators of G-Protein Signalling as New Central Nervous System Drug Targets. Nature Reviews Drug Discovery. 2002, 1: 187-197. 10.1038/nrd747.
Berne RM, Levy MN: Physiology. 1998, St. Louis, MO: Mosby, fourth
Chen C, Grzegorzewski KJ, Barash S, Zhao Q, Schneider H, Wang Q, Singh M, Pukac L, Bell AC, Duan R, Coleman T, Duttaroy A, Cheng S, Hirsch J, Zhang L, Lazard Y, Fischer C, Barber MC, Ma ZD, Zhang YQ, Reavey P, Zhong L, Teng B, Sanyal I, Ruben SM, Blondel O, Birse CE: An Integrated Functional Genomics Screening Program Reveals a Role for BMP-9 in Glucose Homeostasis. Nature Biotechnology. 2003, 21: 294-301. 10.1038/nbt795.
Angel P, Imagawa M, Chiu R, Stein B, Imbra R, Rahmsdorf H, Jonat C, Herrlich P, Karin M: Phorbol Ester-inducible Genes Contain a Common cis Element Recognized by a TPA-modulated trans-acting Factor. Cell. 1987, 49: 729-739. 10.1016/0092-8674(87)90611-8.
Segal R, Greenberg M: Intracellular Signalling Pathways Activated by Neurotrophic Factors. Annual Reveiws in Neuroscience. 1996, 19: 463-489.
Nakabeppu Y, Nathans D: A Naturally Occurring Truncated for of FosB that Inhibits Fos/Jun Transcriptional Activity. Cell. 1991, 64: 751-759. 10.1016/0092-8674(91)90504-R.
O'Brien RM, Granner DK: Regulation of Gene Expression by Insulin. Biochemistry Journal. 1991, 278: 609-619.
Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin-6-type Cytokine Signalling through the gp130/Jak/STAT Pathway. Biochemistry Journal. 1998, 334: 297-314.
Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson S, Ohlsson C, Jansson J: Interleukin-6-deficient Mice Develop Mature-Onset Obesity. Nature Medicine. 2002, 8: 75-79. 10.1038/nm0102-75.
Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M: Role of STAT-3 in Regulation of Hepatic Gluconeogenic Genes and Carbohydrate Metabolism in vivo. Nature Medicine. 2004, 10 (2): 168-174. 10.1038/nm980.
Zechmeister-Machhart M, Hufnagl P, Uhrin P, Korschineck I, Binder B, Geiger M: Molecular Cloning and Sequence Analysis of the Mouse Protein C Inhibitor Gene. Gene. 1997, 186: 61-66. 10.1016/S0378-1119(96)00681-6.
Uphues I, Chern Y, Eckel J: Insulin-dependent Translocation of the Small GTP-binding Protein RAB3C in Cardiac Muscle: Studies on Insulin-Resistant Zucker Rats. FEBS Letters. 1995, 377 (2): 109-112. 10.1016/0014-5793(95)01315-6.